A report, cleared by the CDC’s scientific review process and scheduled for publication in the Morbidity and Mortality Weekly Report, utilized the same methodology also employed by numerous leading medical journals to assess vaccine efficacy. This report, obtained by the Post, found that between September and December 2025, healthy adults vaccinated against COVID-19 experienced a 50 percent reduction in urgent care or emergency room visits and a 55 percent decrease in COVID-related hospitalizations compared to their unvaccinated counterparts. The agency had previously published a similar report on the flu vaccine using this methodology.

Read the original article here

It’s quite concerning to think about the possibility of delays in releasing reports that could clearly demonstrate the effectiveness of COVID-19 vaccines. The idea that a report confirming the success of these vaccines might be held back, especially when there’s so much misinformation circulating, feels like a disservice to public health. It’s as if the science is inconveniently pointing in one direction, and there’s a reluctance to let that truth be fully known.

When you consider the immense effort and scientific achievement that went into developing these vaccines, the notion of suppressing evidence of their success is deeply troubling. These vaccines were a monumental leap forward, offering a crucial tool in combating a global pandemic that caused immense suffering and loss. To deliberately obstruct the confirmation of their efficacy feels like a betrayal of the public trust and the scientific process itself.

There’s a sentiment that this situation reflects a broader issue of anti-science or anti-information narratives taking root in important institutions. It raises questions about who is making these decisions and on what basis. If a report, using established and previously accepted methodologies, is suddenly deemed problematic because it validates the vaccines, it certainly sparks suspicion about the motives behind such a delay.

The implications of delaying such a report are significant. It allows doubt to fester and potentially reinforces existing skepticism. In a world where information, both accurate and inaccurate, travels at lightning speed, having clear, scientifically validated information readily available is paramount. Delays, especially when they appear politically or ideologically motivated, create fertile ground for conspiracy theories and further erode public confidence in health authorities.

It’s understandable why there would be frustration and even anger when something that appears to be a significant scientific success story is met with what seems like an attempt to obscure or delay its positive confirmation. The COVID-19 vaccines, for many, represented a return to normalcy and a way to protect themselves and their loved ones. To question their efficacy, or to actively delay proof of their success, feels counterintuitive to the goal of protecting public well-being.

The narrative around vaccine development and deployment has been complex, to say the least. However, when faced with the prospect of a report that unequivocally shows the vaccines worked, its suppression or delay raises serious questions about the agenda being pursued. It’s a situation that calls for transparency and a commitment to letting the scientific evidence speak for itself, especially when so much is at stake for public health.